You've created quite a fan club...
On "IGNORE" that is! (But red-thumbed, first.)
IGGY button exercised!
Make no mistake about it, this was not one "little boy."
It's part of the larger crime syndicate which runs Wall Street, hedge funds, and part of the SEC.
One behavior you'll notice is that some days you'll see massive numbers of posts made by "shorts," while other days you'll see virtually none. If this were truly a randomized sample of random bashers, you wouldn't see that behavior. It lends further credence that these are highly organized attacks made for the specific purpose to bring a stock down.
They did all they could do to INO (for the moment). It's unfortunate that the infestation has spread here.
Dude, you better look in the mirror. Why are you trying to "scare us" from these posters?
What are YOU afraid of?
The whole world will open up to INO if we get positive P2 results in a few weeks.
One parameter that I'm not clear about is the "80% power" part of the statistics analysis that is cited for the trial.
For you statistics gurus, what does this mean in laymen's terms? Thanks!
At some point big pharma will NEED to make an offer for INO. Remember, there is ultimately a price for everything.
I believe that sometime within the next two years INO will receive offers north of $10B for the company. Depending on trial results, even this number may be on the low side.
Onward, upward, and away!
Thanks Regrose... The appreciation is mutual.
It is very difficult to extrapolate pricing beyond a year or two as I believe big pharma will NEED to make an offer at some point to acquire the company. At the end of the day, there is a "price" on everything, and I believe that Dr. Kim would ultimately sell the company, if the price was right. I hope it's not for awhile yet. I have a feeling that it will be north of $10B sometime within two years.
But what is that price? No one knows right now, probably not even Dr. Kim. And that' putting the cart before the horse. We need to continue the upward momentum with more trial successes and partnerships.
Up, up, and away!
It will only partially validate ONCS' value proposition.
That said, positive HPV P2 results for INO certainly will not hurt ONCS, and should provide some positive effect on the PPS, but the effect won't be huge, IMHO.
We need news from the FDA or news of a partnership to drive the PPS substantially higher.
relatively cheap (e.g. less than $5B). If the successes continue to mount, and big pharma waits too long, the market could be well north of $10B), should Dr. Kim decide to sell. Remember, everything can be bought for a price, including INO.
But let's first get a runner on base and score with the FDA!
Sentiment: Strong Buy
A successful VGX-3100 trial is a very important milestone, but INO isn't using it's full bag of tricks on this pony. Having said that, we still could be pleasantly surprised by the results. It's INO's lead-off hitter. We need for it to get on base.
VGX-3112 is not INO's clean-up hitter, but it's a trial which will even more fully validate INO's capabilities. It will also help INO design better trials in the future. It will move runners along and drive some in.
The hTERT trial could be INO's clean-up hitter and they could hit a "grand-slam" with a universal cancer vaccine. It could be the holy grail of combination therapies, included in all cancer treatments. I am very interested to see how this research proceeds!
The breadth of the current pipeline is astounding and is easily as large as many big pharma companies. Now all we have to do is work on the depth through positive trial successes. That will take time, and patience will be necessary.
If we continue to successfully move forward through P2 trials, I believe that big pharma will make a huge play for the company, in order to get it while it's relatively cheap (e.g.
Sentiment: Strong Buy
I hope you get out of ONCS (thereby causing it's price to inexplicably move higher, benefiting all of us) and that you make tons of money in FB.
No zero sum game in this case. Everyone wins! :)
I don't believe the HPV P2 data release to be a true binary event, but rest assured it will be the most important event in the company's history. Failure will put a lot of pressure on VGX-3112 to succeed. Success will validate the technology platform and approach.
P2 failure =~70% haircut
P2 success =~ 70-150% pop (depending on the data)
I believe success probability to be about 80%.